SNDX | Syndax Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: Waltham, Massachusetts, United States Trade prices Volume: Market Cap: 1.07B Prev closed: Open: 17.84 High: 18.46 Low: 17.18 52 week low: 13.02 52 week high: 27.12 Dividends: No Dividends Next ER: May 8, 2023
Company Profile Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Through our pipeline agents, entinostat, a late stage, class 1 specific HDAC inhibitor and SNDX-6352, a phase 1 anti-CSF-1R monoclonal antibody, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax corporate headquarters are in Waltham, MA.
Earnings History Date EPS / Forecast Revenue / Forecast August 7, 2023 May 8, 2023 -0.59 / -0.65- / 800KFebruary 28, 2023 -0.62 / -0.65- / 1.6MNovember 7, 2022 - / -0.665- / 1.5MAugust 8, 2022 -0.62 / -0.6367- / 1.38Mview more
Historical Data Date Price Open High Low Vol Change ER May 2, 2023 19.79 20.84 20.87
19.65
843K -5.94% May 1, 2023 21.04 20.59 21.23
20.59
916K 2.38% Apr 28, 2023 20.55 20.38 20.77
20.21
561K 0.83% Apr 27, 2023 20.38 20.97 21.5
20.36
537K -2.07% Apr 26, 2023 20.81 21.08 21.37
20.69
488K -1.42% Apr 25, 2023 21.11 21.13 21.43
20.91
430K -0.8% Apr 24, 2023 21.28 21.5 21.58
21.04
400K -1.02% Apr 21, 2023 21.5 21.58 21.67
21.26
504K -0.14% Apr 20, 2023 21.53 20.65 22
20.65
1.0M 3.51% Apr 19, 2023 20.8 20.29 20.97
20.11
436K 1.96% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Syndax Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Business Update finance.yahoo.com Dec 10, 2021 4:01 pm
Syndax Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Dec 10, 2021 2:30 pm
Syndax Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Dec 10, 2021 2:30 pm
Syndax Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Dec 10, 2021 1:30 pm
Syndax Announces Positive Interim Data Demonstrating Robust Clinical Activity in Phase 1 Portion of the AUGMENT-101 Trial of SNDX-5613 in Patients with Genetically-Defined Acute Leukemias finance.yahoo.com Dec 10, 2021 7:00 am
Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab finance.yahoo.com Dec 9, 2021 4:05 pm Syndax Pharmaceuticals EPS misses by $0.35, misses on revenue seekingalpha.com Nov 16, 2021 5:16 am Syndax Pharmaceuticals Q3 2021 Earnings Preview seekingalpha.com Nov 15, 2021 6:35 am Syndax Pharma falls after updating early-stage data for leukemia therapy seekingalpha.com Nov 5, 2021 3:20 am
Should I Avoid Syndax Pharmaceuticals, Inc. (SNDX)? finance.yahoo.com Oct 25, 2021 5:05 pm
Biotech Stock Roundup: XLRN Up on Takeover Rumor, NVAX, BIIB Offer Updates & More finance.yahoo.com Sep 29, 2021 10:47 am
Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate finance.yahoo.com Sep 27, 2021 9:23 am
Is Syndax Pharmaceuticals (NASDAQ:SNDX) Using Too Much Debt? finance.yahoo.com Aug 23, 2021 11:22 am
The Syndax Pharmaceuticals (NASDAQ:SNDX) Share Price Is Up 157% And Shareholders Are Boasting About It finance.yahoo.com Jun 24, 2021 7:01 am
Syndax Pharmaceuticals Reports Fourth Quarter 2020 Financial Results and Provides Clinical and Business Update finance.yahoo.com May 12, 2021 4:05 pm
Is SNDX Stock A Buy or Sell? finance.yahoo.com May 12, 2021 1:38 pm Syndax Lower as Blood Cancer Drug Trial Disappoints Investors thestreet.com May 12, 2021 9:40 am
Implied Volatility Surging for Syndax Pharmaceuticals (SNDX) Stock Options finance.yahoo.com May 12, 2021 8:54 am
Syndax Pharma Updates On Interim Phase 1 Data From SNDX-5613 Leukemia Trial finance.yahoo.com May 12, 2021 7:51 am Syndax Pharma announces new data for SNDX-5613 in trial for acute leukemias seekingalpha.com May 12, 2021 4:32 am This company doesn't provide a dividend.
Key Persons CEO : W. Morrison CFO : Daphne Karydas Treasurer : Daphne Karydas Chief Medical Officer : Michael L. Meyers Talk about Syndax Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 75 HOLD 25 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet